CLINICAL_TRIALS
trial_result
· 2015-07-28
Clinical Trial Update: Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT [Phase 3]
Summary
Phase 3 clinical trial update on rechallenge of Imatinib in gastrointestinal stromal tumors after prior treatment failures; study completed with results posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Asan Medical Center | Conditions: Gastrointestinal Stromal Tumors | Phase 3 | Status: COMPLETED | Results posted: 2015-07-28